Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
|
| gptkbp:activeIngredient |
gptkb:heparin_sodium
|
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:availableOn |
gptkb:government_agency
|
| gptkbp:contraindication |
gptkb:heparin-induced_thrombocytopenia
active bleeding |
| gptkbp:drugClass |
gptkb:anticoagulant
|
| https://www.w3.org/2000/01/rdf-schema#label |
Hep-Lock
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:marketedIn |
gptkb:United_States
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
bleeding
allergic reaction |
| gptkbp:usedFor |
preventing blood clots in intravenous lines
|
| gptkbp:usedIn |
hospitals
clinics |
| gptkbp:bfsParent |
gptkb:Heparin
|
| gptkbp:bfsLayer |
6
|